Natera

Natera

World Rank (Aug-2026)
584
Market Cap (Aug-2026)
44.675 Billion USD
World Rank (Jan-05-2024)
2,195
Market Cap (Jan-05-2024)
7.172 Billion USD
World Rank (Jul-30-2023)
2,840
Market Cap (Jul-30-2023)
5.244 Billion USD
World Rank (Jan-07-2022)
2,489
Market Cap (Jan-07-2022)
7.109 Billion USD
World Rank (Jan-01-2021)
1,914
Market Cap (Jan-01-2021)
8.496 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 949
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
NTRA
Employee Count
3,018
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
2,306 Million USD
Annual Operating Income in USD
-310 Million USD
Annual Net Income in USD
-208 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,398 Million USD
Total Liabilities in USD
686 Million USD
Total Equity in USD
1,712 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Health Care Diagnostics
Company Website
NATERA INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Natera is a Genetic Carrier Screening and Miscarriage Testing company. The headquarters is in USA.

Annual Results Summary

NATERA - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-2022820363-541 (Loss)-547 (Loss)
Dec-2021625307-468 (Loss)-471 (Loss)
Dec-2020391.0187216 (Loss)229 (Loss)
Dec-2019302.3126116.3) (Loss)124.8 (Loss)
Dec-2018257.791114 (Loss)128 (Loss)
Dec-2017209.670135 (Loss)137 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,394 Million USD.

Total Liabilities as on Dec-2022 was 688 Million USD.

Total Equity as on Dec-2022 was 705 Million USD.

Founded Year
2004
IPO Year
2015
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medical Specialities

Share